A molecular mechanism of VD on CIA arthritis appears to be via a direct effect on T cells and/or indirectly on APCs by restraining Th17 cells differentiation via miR-124-mediated inhibition of IL-6 signaling, indicating that VD may have treatment implications in rheumatoid arthritis. The gene discussed is IL6; the disease is arthritic joint disease.